GANDOLFO, CLAUDIA
 Distribuzione geografica
Continente #
EU - Europa 2.224
NA - Nord America 1.884
AS - Asia 498
SA - Sud America 171
AF - Africa 29
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 4.811
Nazione #
US - Stati Uniti d'America 1.867
IT - Italia 509
IE - Irlanda 499
GB - Regno Unito 366
SE - Svezia 180
RU - Federazione Russa 179
SG - Singapore 171
BR - Brasile 157
CN - Cina 147
DE - Germania 131
FR - Francia 99
FI - Finlandia 93
HK - Hong Kong 61
UA - Ucraina 60
VN - Vietnam 33
IN - India 30
BE - Belgio 19
NL - Olanda 18
ES - Italia 16
TR - Turchia 15
CI - Costa d'Avorio 10
AT - Austria 9
IM - Isola di Man 9
PL - Polonia 9
CZ - Repubblica Ceca 8
CA - Canada 7
ZA - Sudafrica 7
PK - Pakistan 6
MX - Messico 5
BD - Bangladesh 4
IR - Iran 4
MA - Marocco 4
MT - Malta 4
BG - Bulgaria 3
EU - Europa 3
JP - Giappone 3
TH - Thailandia 3
UZ - Uzbekistan 3
AL - Albania 2
AR - Argentina 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EC - Ecuador 2
EG - Egitto 2
IL - Israele 2
IQ - Iraq 2
PH - Filippine 2
PT - Portogallo 2
PY - Paraguay 2
RO - Romania 2
UY - Uruguay 2
VE - Venezuela 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BO - Bolivia 1
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
EE - Estonia 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
ID - Indonesia 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LU - Lussemburgo 1
MK - Macedonia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
QA - Qatar 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 4.811
Città #
Dublin 484
Southend 308
Chandler 222
Fairfield 204
Santa Clara 173
Siena 165
Ashburn 129
Wilmington 91
Singapore 83
Ann Arbor 75
Woodbridge 74
Houston 72
Cambridge 71
Princeton 68
Seattle 66
Helsinki 63
Hong Kong 61
New York 54
Jacksonville 52
Beijing 50
Milan 47
Munich 45
Rome 38
Florence 30
Fremont 27
Dong Ket 25
Menlo Park 24
Los Angeles 20
San Mateo 17
Brussels 16
Shanghai 16
Boardman 15
Málaga 14
Lauterbourg 13
Nanjing 13
San Diego 13
Turku 13
Moscow 12
Lancaster 11
Nuremberg 11
Abidjan 10
Düsseldorf 10
Dearborn 9
Falls Church 9
Portsmouth 9
São Paulo 9
Douglas 8
Izmir 8
London 8
The Dalles 8
Warsaw 8
Bengaluru 7
Frankfurt am Main 7
Karlsruhe 7
Messina 7
Rio de Janeiro 7
Shenyang 7
Council Bluffs 6
Espoo 6
Norwalk 6
Falkenstein 5
Poli 5
Vienna 5
Washington 5
Abbiategrasso 4
Cagliari 4
Campofilone 4
Hebei 4
Istanbul 4
Marano Di Napoli 4
Massa 4
Modena 4
Nanchang 4
Pescara 4
Pontedera 4
Amsterdam 3
Bari 3
Belo Horizonte 3
Brescia 3
Brno 3
Chiari 3
Chicago 3
Dallas 3
Guarulhos 3
Lappeenranta 3
Leawood 3
Mumbai 3
Newark 3
Ningbo 3
Padova 3
Ribeirão Preto 3
San Francisco 3
Sumaré 3
Tashkent 3
Trieste 3
Turin 3
Zanjan 3
Andover 2
Ankara 2
Boston 2
Totale 3.277
Nome #
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 265
A Respiratory Syncytial Virus Vaccine Vectored by a Stable Chimeric and Replication-Deficient Sendai Virus Protects Mice without Inducing Enhanced Disease 260
Phase Ib study of poly-epitope peptide vaccination to thymidylate synthase (TSPP) and GOLFIG chemo-immunotherapy for treatment of metastatic colorectal cancer patients 253
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients 192
Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients 189
Host-pathogen interaction: study of Toscana virus 176
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). 173
Whole-Genome Sequence of SARS-CoV-2 Isolate Siena-1/2020 169
Overview of Anti-SARS-CoV-2 Immune Response Six Months after BNT162b2 mRNA Vaccine 147
Antibody response to SARS-CoV-2 in infected patients with different clinical outcome 145
Seroprevalence to measles virus after vaccination or natural infection in an adult population, in Italy 140
Immune-inflammatory markers predict the outcome of metastatic colorectal cancer patients treated with the thymidylate synthase poly-epitope peptide (TSPP) vaccine: results from a multi-arm TSPP/VAC phase lb program 136
SARS-CoV-2 Antibody Response in Persons with Past Natural Infection 116
Toscana virus non-structural protein NSs acts as E3 ubiquitin ligase promoting RIG-I degradation 115
Ubiquitin and not only unfolded domains drives toscana virus non-structural NSs protein degradation 115
Identification of a neutralizing epitope on tosv gn glycoprotein 113
null 112
Detection of asymptomatic SARS-CoV-2 infections among healthcare workers: Results from a large-scale screening program based on rapid serological testing 111
Epidemiology of Toscana virus in South Tuscany over the years 2011-2019 109
Hepatitis C Virus Core Antigen (HCVAg): an affordable assay to monitor the efficacy of treatment in DAAs era 107
null 103
How long can SARS-CoV-2 persist in human corpses? 103
Infection prevention in endoscopy practice; comparative evaluation of reusable vs single use endoscopic valves 102
Infectious Toscana virus in seminal fluid of young man returning from Elba Island, Italy 99
Residual SARS-CoV-2 RNA in nasal swabs of convalescent COVID-19 patients: Is prolonged quarantine always justified? 98
Neutralizing antibody response of vaccinees to SARS-CoV-2 variants 94
Efficient inactivation of sars-cov-2 and other rna or dna viruses with blue led light 94
Alcohol intake and the risk of intracerebral hemorrhage in the elderly: The MUCH-Italy 93
Human Polymorphonuclear Cells Support Zika Virus to Cross Endothelial Monolayer and Access Bloodstream 93
PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approach 92
Rational Use of Monoclonal Antibodies as Therapeutic Treatment in an Oncologic Patient with Long COVID 91
Comparative performance of a new sars-cov-2 rapid detection system 87
Omicron infection evokes cross-protection against SARS-CoV-2 variants in vaccinees 86
Hyperimmune plasma in three immuno-deficient patients affected by non-severe, prolonged COVID-19: a single-center experience 85
SARS-CoV-2 infection in cancer patients on active therapy after the booster dose of mRNA vaccines 76
Severe acute respiratory syndrome coronavirus 2 vaccination and cancer therapy: A successful but mindful mix 67
SARS-CoV-2 n protein targets TRIM25-mediated RIG-I activation to suppress innate immunity 56
Detection of SARS-CoV-2 N protein allelic variants by rapid high-throughput CLEIA antigen assay 55
Validation of Two Commercial Multiplex Real-Time PCR Assays for Detection of SARS-CoV-2 in Stool Donors for Fecal Microbiota Transplantation 54
Nucleopore Traffic Is Hindered by SARS-CoV-2 ORF6 Protein to Efficiently Suppress IFN-β and IL-6 Secretion 53
Antibody Response against Circulating Omicron Variants 8 Months after the Third Dose of mRNA Vaccine 50
Toscana virus infects dendritic and endothelial cells opening the way for the central nervous system 47
Truncation of the C-terminal region of Toscana Virus NSs protein is critical for interferon-β antagonism and protein stability 45
Totale 4.966
Categoria #
all - tutte 21.252
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.252


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202020 0 0 0 0 0 0 0 0 0 0 0 20
2020/2021627 12 42 7 37 27 103 77 57 58 83 39 85
2021/2022529 34 33 24 39 23 27 21 16 99 45 57 111
2022/2023773 43 93 100 82 77 158 19 74 60 25 25 17
2023/2024868 25 51 70 48 35 214 309 24 7 14 16 55
2024/20251.378 57 62 158 95 167 99 96 99 162 83 160 140
Totale 4.966